XML 12 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
BALANCE SHEETS - USD ($)
Jun. 30, 2018
Sep. 30, 2017
CURRENT ASSETS:    
Cash and cash equivalents $ 2,346,650 $ 2,369,438
Receivables 119,652 218,481
Prepaid expenses 346,431 826,429
Deposits - current portion 0 150,000
Inventory used for R&D and manufacturing 628,158 672,522
Total current assets 3,440,891 4,236,870
Plant, property and equipment, net 16,361,651 16,793,220
Patent costs, net 227,166 223,167
Deposits 1,670,917 1,670,917
Total Assets 21,700,625 22,924,174
CURRENT LIABILITIES:    
Accounts payable 6,253,497 8,196,334
Accrued expenses 861,842 936,698
Due to employees 1,242,813 693,831
Notes payable 0 994,258
Derivative instruments, current portion 4,916 10,984
Other current liabilities 14,290 12,449
Total current liabilities 8,377,358 10,844,554
Derivative instruments - net of current portion 1,076,400 2,042,418
Lease Liability 13,336,969 13,211,925
Deferred revenue 126,795 125,000
Other liabilities 34,837 37,254
Total liabilities 22,952,359 26,261,151
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' DEFICIT    
Preferred stock, $.01 par value-200,000 shares authorized; -0- shares issued and outstanding 0 0
Common stock, $.01 par value - 600,000,000 shares authorized; 19,570,468 and 11,903,133 shares issued and outstanding at June 30, 2018 and September 30, 2017, respectively 195,706 119,031
Additional paid-in capital 315,217,502 296,298,401
Accumulated deficit (316,664,942) (299,754,409)
Total stockholders' deficit (1,251,734) (3,336,977)
TOTAL LIABILITIES AND STOCKHOLDERS DEFICIT $ 21,700,625 $ 22,924,174